Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Roberta Modica, Alessia Liccardi, Roberto Minotta, Giuseppe Cannavale, Elio Benevento & Annamaria Colao. (2023) Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms. Expert Review of Endocrinology & Metabolism 0:0, pages 1-13.
Read now
Read now
Helge L. Waldum & Jens F. Rehfeld. (2019) Gastric cancer and gastrin: on the interaction of Helicobacter pylori gastritis and acid inhibitory induced hypergastrinemia. Scandinavian Journal of Gastroenterology 54:9, pages 1118-1123.
Read now
Read now
Federica Cavalcoli, Alessandra Zilli, Dario Conte, Clorinda Ciafardini & Sara Massironi. (2015) Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence?. Scandinavian Journal of Gastroenterology 50:11, pages 1397-1403.
Read now
Read now
Louis de Mestier, Marie-Danièle Diebold, Franck Devulder, Remi Picot & Guillaume Cadiot. (2015) Gastric carcinoids escaping the currently available classification. Scandinavian Journal of Gastroenterology 50:5, pages 621-622.
Read now
Read now
Articles from other publishers (16)
Soichiro Nagao, Yohei Yabuuchi, Kosuke Tanaka, Yoshiki Morihisa, Takuya Kobayashi, Shinsuke Akiyama, Gensho Tanke, Masaya Wada, Shuko Morita, Satoko Inoue, Hiroshi Tei, Daisuke Yamashita & Tetsuro Inokuma. (2024) Multiple Gastric Neuroendocrine Tumors Associated with Long-term Use of a Proton Pump Inhibitor and a Potassium-competitive Acid Blocker. Internal Medicine.
Crossref
Crossref
Helge Waldum & Patricia Mjønes. (2023) The central role of gastrin in gastric cancer. Frontiers in Oncology 13.
Crossref
Crossref
Rachele Biancotti, Carlo Alberto Dal Pozzo, Paola Parente, Gianluca Businello, Valentina Angerilli, Stefano Realdon, Edoardo Vincenzo Savarino, Fabio Farinati, Anna Caterina Milanetto, Claudio Pasquali, Roberto Vettor, Federica Grillo, Gianmaria Pennelli, Claudio Luchini, Luca Mastracci, Alessandro Vanoli, Massimo Milione, Francesca Galuppini & Matteo Fassan. (2023) Histopathological Landscape of Precursor Lesions of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms. Digestive Diseases 41:1, pages 34-48.
Crossref
Crossref
Vincent Q‐H Trinh, Chanjuan Shi & Changqing Ma. (2020) Gastric neuroendocrine tumours from long‐term proton pump inhibitor users are indolent tumours with good prognosis. Histopathology 77:6, pages 865-876.
Crossref
Crossref
Denis M. McCarthy. (2020) Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids—What Is the Relationship?. International Journal of Molecular Sciences 21:2, pages 662.
Crossref
Crossref
Reidar Fossmark, Tom C. Martinsen & Helge L. Waldum. (2019) Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility. International Journal of Molecular Sciences 20:20, pages 5203.
Crossref
Crossref
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito & Robert T. Jensen. (2019) Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences 20:20, pages 5128.
Crossref
Crossref
Francesco Panzuto, Davide Campana, Sara Massironi, Antongiulio Faggiano, Maria Rinzivillo, Giuseppe Lamberti, Valentina Sciola, Edith Lahner, Lisa Manuzzi, Annamaria Colao & Bruno Annibale. (2019) Tumour type and size are prognostic factors in gastric neuroendocrine neoplasia: A multicentre retrospective study. Digestive and Liver Disease 51:10, pages 1456-1460.
Crossref
Crossref
B-H Min, M Hong, J H Lee, P-L Rhee, T S Sohn, S Kim, K-M Kim & J J Kim. (2018) Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours. British Journal of Surgery 105:11, pages 1480-1486.
Crossref
Crossref
Yuichi Kojima, Toshihisa Takeuchi, Makoto Sanomura, Ken Higashino, Keishi Kojima, Kenji Fukumoto, Kou Takata, Hiroki Sakamoto, Masahiro Sakaguchi, Kazunari Tominaga & Kazuhide Higuchi. (2018) Does the Novel Potassium-Competitive Acid Blocker Vonoprazan Cause More Hypergastrinemia than Conventional Proton Pump Inhibitors? A Multicenter Prospective Cross-Sectional Study. Digestion 97:1, pages 70-75.
Crossref
Crossref
Federica Cavalcoli, Aoife Garrahy, Marco Castellaneta & Gianluca Tamagno. 2018. Neuroendocrine Tumors in Real Life. Neuroendocrine Tumors in Real Life
3
27
.
Lianhuang Li, Liwei Jiang, Zhifen Chen, Deyong Kang, Zhenrong Yang, Xing Liu, Weizhong Jiang, Shuangmu Zhuo, Guoxian Guan, Yongjian Zhou & Jianxin Chen. (2016) Nonlinear optical microscopy for label-free detection of gastrointestinal neuroendocrine tumors. Lasers in Medical Science 31:7, pages 1285-1291.
Crossref
Crossref
Vincenzo Savarino, Pietro Dulbecco & Edoardo Savarino. (2016) Are proton pump inhibitors really so dangerous?. Digestive and Liver Disease 48:8, pages 851-859.
Crossref
Crossref
Nina Nandy, Joshua A. Hanson, Robert G. Strickland & Denis M. McCarthy. (2015) Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature. Digestive Diseases and Sciences 61:3, pages 708-712.
Crossref
Crossref
G. Delle Fave, D. O''Toole, A. Sundin, B. Taal, P. Ferolla, J.K. Ramage, D. Ferone, T. Ito, W. Weber, Z. Zheng-Pei, W.W. De Herder, A. Pascher & P. Ruszniewski. (2016) ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms. Neuroendocrinology 103:2, pages 119-124.
Crossref
Crossref
Andrea Cavallaro, Antonio Zanghì, Marco Cavallaro, Emanuele Lo Menzo, Isidoro Di Carlo, Maria Di Vita, Francesco Cardì, Gaetano Piccolo, Paolo Di Mattia & Alessandro Cappellani. (2014) The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: Our experience: A case report. International Journal of Surgery 12, pages S225-S231.
Crossref
Crossref